Phase 3 N=170 Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection
Injury of Body of Pancreas
Primary: Number of Participants With Biochemical Leak/Grade B Fistula/Grade C Fistula — 25; 16; 3; 5 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=14 ABRA Abdominal Closure System in Open Abdomen Management
Open Abdomen
Primary: Primary Closure Rate — 75; 67 % of participants
N/A N=9 Left Atrial Appendage Closure With SentreHeart Lariat® Device
Cardioembolic Stroke · Atrial Fibrillation
Primary: Number of Participants With Successful Stand-Alone Left Atrial Appendage Closure Using SentreHeart Lariat Device as Measured by Left Atrial Appendage Closure Rates — 6…
N/A N=30 Implant Surface Decontamination in Peri-implantitis Treatment
Peri-implantitis · Periodontal Disease
Primary: Change in Total Bacterial Load on the Exposed Implant Surface — 2.77; 4.21 log (colony forming units/ml)
N/A N=60 Use of Knotless Suture for Closure of Total Hip and Knee Arthroplasties
Knee Osteoarthritis · Hip Osteoarthritis
Primary: Closure Time — 9.34; 13.57 Average time in minutes
Phase 4 N=100 Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).
Atrial Fibrillation · Device Related Thrombus · Left Atrial Appendage Thrombosis
Primary: Device Related Thrombus (DRT) at 90 Days — 1 Participants
N/A N=35 The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial
Left Atrial Appendage Closure · WATCHMAN Device Implantation
Primary: Comparison of Thrombin Induced Platelet-fibrin Clot Strength (TIP-FCS) Between Patients With and Without Device Related Thrombosis (DRT) Assessed at 1-year of Watchman…
N/A N=1,600 Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Atrial Fibrillation
Primary: Primary Effectiveness Endpoint: Stroke, All Cause Death, and Systemic Embolism — 44; 41 Participants
N/A N=160 Multimodality Evaluation of LAA Leaks Arising After Incomplete LAAC: Insights From the LAA-Leak Registry
Left Atrail Appendage Closure: Peri-device Leaks
Primary: Size of PDL After Leak Closure Procedure — 0; 0; 0; 64 Participants
N/A N=74 Randomized Controlled Trial of Subcuticular Skin Closure Versus Steri-strip S Closure
Breast Hypertrophy · Abdominal Elastosis · Breast Reconstruction
Primary: Scar Quality at 6 Months Postoperative — 3.8; 2.6 units on a scale
N/A N=109 Comparison of Topical Skin Adhesive to Subcuticular Suture Closure of Implantable Port Incisions
Port-A-Cath Placement · Octylcyanoacrylate
Primary: Number of Participants With Complication of Wound Dehiscence — 0; 0 participants
Phase 3 N=104 Biological Mesh Closure of the Pelvic Floor After Extralevator Abdomino Perineal Resection for Rectal Cancer
Rectal Cancer
Primary: 30-day Uncomplicated Perineal Wound Healing — 30; 33 Participants
N/A N=100 Study of Intra-Cardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With the Watchman Device
Left Atrial Appendage Occlusion
Primary: Successful Implantation of WATCHMAN FLX Device — 96 Participants
Phase 3 N=407 Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
Atrial Fibrillation · Stroke
Primary: Primary Safety Endpoint (Device Group Only) — 6 Participants
N/A N=80 A Study of Sternal Closure After Open Heart Surgery: Rigid Versus Wire Closure
Pain
Primary: Intubation Time — 7; 9 hours